Anne G. Graham

Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site

Christopher Pargellis, Liang Tong, Laurie Churchill et al. · Nature Structural Biology · 2002 · 832 citations · Full text

Molecular Pharmacology, Drug Target, Molecular Physiology +11

Pyrazole Urea-Based Inhibitors of p38 MAP Kinase:  From Lead Compound to Clinical Candidate

John R. Regan, Steffen Breitfelder, Pier F. Cirillo et al. · Journal of Medicinal Chemistry · 2002 · 349 citations · Full text

Drug Target, P38 Map Kinase, Atp Binding Site +20

Structure−Activity Relationships of the p38α MAP Kinase Inhibitor 1-(5-<i>tert</i>-Butyl-2-<i>p</i>-tolyl-2<i>H</i>-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796)

John R. Regan, Alison J. Capolino, Pier F. Cirillo et al. · Journal of Medicinal Chemistry · 2003 · 105 citations · Full text

Drug Target, Birb 796, Chemical Biology +18

Effect of Structural Modification of Enol−Carboxamide-Type Nonsteroidal Antiinflammatory Drugs on COX-2/COX-1 Selectivity

Edward S. Lazer, Clara K. Miao, Charles L. Cywin et al. · Journal of Medicinal Chemistry · 1997 · 92 citations · Full text

Selective inhibition of human cyclo-oxygenase-2 by meloxicam

Laurie Churchill, Anne G. Graham, C-K. Shih et al. · Inflammopharmacology · 1996 · 92 citations

Selective Inhibition, Medicinal Chemistry, Biochemistry +6